why choose us

First received: August 16, 2024

Clinical Trial: Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Weight Loss

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 13-week Study of NA-931 for Weight Management in Subjects Who Are Obese or Overweight With at Least One Weight-related Comorbid Condition

Brief Summary: This is a Phase 2 randomized, double-blind, placebo-controlled, parallel arm study of NA-931 in adults who are obese (BMI ?30 kg/m2) or who are overweight (BMI ?27 kg/m2) with at least one weight-related co-morbid condition.

Read more